Kadimastem Ltdis A Biotechnology Company Based In Ness Zionaisraelfocused On Regenerative Medicine And The Development Of Stem Cell Based Therapeuticsfounded In 2008 By Yossi Ben Yosef And Michel Revelthe Company Is Listed On The Tel Aviv Stock Exchange Under The Ticker Symbol Kdst The Company Specializes In Creating Off The Shelf Cell Products Using Human Embryonic And Engineered Pluripotent Stem Cellsnotable Products Include Astrorxa Cryopreserved Cell Product Aimed At Treating Amyotrophic Lateral Sclerosisals And Isletrxa Diabetes Treatment That Employs Patented Cell Selection Technologykadimastem Has Formed Strategic Partnerships With Organizations Like Nls Pharmaceutics And Itolerance To Enhance Its Diabetes Treatment Initiatives Kadimastem Is Also Pursuing A Potential Listing On The Nasdaq Through A Merger With A Nasdaq Listed Companyreflecting Its Ambition To Broaden Its Impact In The Global Biotechnology Sector
No conferences found for this company.
| Company Name | Kadimastem Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
